Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Liam Grogan
Frequency, Impact and a Preclinical Study of Novel ERBB Gene Family Mutations in HER2-positive Breast Cancer
Therapeutic Advances in Medical Oncology
Oncology
Related publications
A Novel HER2-positive Breast Cancer Phenotype Arising From Germline TP53 Mutations
Journal of Medical Genetics
Genetics
Novel Approaches to Target HER2-positive Breast Cancer: Trastuzumab Emtansine
Cancer Management and Research
Oncology
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Relapsed Classic E-Cadherin (CDH1)-Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations
Clinical Cancer Research
Cancer Research
Oncology
Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
Increased Mortality in HER2 Positive, Oestrogen Receptor Positive Invasive Breast Cancer: A Population-Based Study
British Journal of Cancer
Cancer Research
Oncology
Brain Metastases in Asian HER2-positive Breast Cancer Patients: Anti-Her2 Treatments and Their Impact on Survival
British Journal of Cancer
Cancer Research
Oncology
Pcn74 - A Budget-Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early Her2-Positive Breast Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology